药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Cyproterone acetate
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Cyproterone acetate.
Tetracosactide
Vorinostat
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Vorinostat.
Tetracosactide
Danazol
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Danazol.
Tetracosactide
Methotrimeprazine
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Methotrimeprazine.
Tetracosactide
Drospirenone
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Drospirenone.
Tetracosactide
Ephedra sinica root
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Ephedra sinica root.
Tetracosactide
Mestranol
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Mestranol.
Tetracosactide
Metahexamide
Linagliptin may increase the hypoglycemic activities of Metahexamide.
Tetracosactide
Carbutamide
Linagliptin may increase the hypoglycemic activities of Carbutamide.
Tetracosactide
Glibornuride
Linagliptin may increase the hypoglycemic activities of Glibornuride.
Tetracosactide
Glisoxepide
Linagliptin may increase the hypoglycemic activities of Glisoxepide.
Tetracosactide
Lumacaftor
The serum concentration of Linagliptin can be decreased when it is combined with Lumacaftor.
Tetracosactide
Imipramine oxide
Imipramine oxide may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Iprindole
Iprindole may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Lofepramine
Lofepramine may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Melitracen
Melitracen may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Quinupramine
Quinupramine may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Dibenzepin
Dibenzepin may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Amitriptylinoxide
Amitriptylinoxide may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Opipramol
Opipramol may decrease the hypoglycemic activities of Linagliptin.